Sarepta reports 1 death after patient received DMD gene therapy Elevidys
One patient with Duchenne muscular dystrophy has passed away following treatment with Sarepta Therapeutics’ gene therapy Elevidys, the biotech said Tuesday.

Mar 18, 2025 0
Mar 18, 2025 0
Mar 18, 2025 0
Mar 18, 2025 0
Mar 18, 2025 0
Mar 16, 2025 0
Mar 16, 2025 0
Mar 16, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Mar 18, 2025 0
Mar 18, 2025 0
Mar 18, 2025 0
Mar 18, 2025 0
Or register with email
Feb 9, 2025 0
Feb 10, 2025 0
Feb 11, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 13, 2025 0
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.